Patent details

EP1159003 Title: ANTI-TNF ALPHA ANTIBODIES IN THERAPY OF STEROID RESISTANT ASTHMA

Basic Information

Publication number:
EP1159003
PCT Application Number:
PCT/US/2000/005163
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009120650
PCT Publication Number:
WO/2000/051637
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-TNF ALPHA ANTIBODIES IN THERAPY OF STEROID RESISTANT ASTHMA
French Title of Invention:
ANTICORPS ANTI-TNF ALPHA UTILISÉS DANS LA THÉRAPIE DE L'ASTHME RÉSISTANT AUX STÉROIDES
German Title of Invention:
ANTIKÖRPER GEGEN TNF ALPHA ZUR THERAPIE VON STEROIDRESISTENTEM ASTHMA
SPC Number:

Dates

Filing date:
01/03/2000
Grant date:
17/11/2010
EP Publication Date:
17/11/2010
PCT Publication Date:
08/09/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/12/2001
EP B1 Publication Date:
17/11/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/03/2019
Expiration date:
01/03/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/06/2014
 
 

Name:
JANSSEN BIOTECH, INC.
Address:
800/850 RIDGEVIEW DRIVE, HORSHAM, PA 19044, United States (US)

History of Owners

From:
07/09/2011
To:
02/06/2014

Name:
Centocor Ortho Biotech Inc.
Address:
800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)

Agent

Name:
LECOMTE & PARTNERS SÀRL
From:
01/02/2011
Address:
76-78, rue de Merl, L-2146, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

Name:
TREACY George
Address:
United States (US)

Priority

1

Priority Number:
260953
Priority Date:
02/03/1999
Priority Country:
United States (US)

2

Priority Number:
465691
Priority Date:
17/12/1999
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
08/02/2018
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
281 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages